SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-031150
Filing Date
2024-08-12
Accepted
2024-08-12 07:35:32
Documents
78
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1205442
2 ex31-1.htm EX-31.1 11621
3 ex31-2.htm EX-31.2 11434
4 ex32.htm EX-32 7155
  Complete submission text file 0001493152-24-031150.txt   7140026

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE abeo-20240630.xsd EX-101.SCH 48236
6 XBRL CALCULATION FILE abeo-20240630_cal.xml EX-101.CAL 69508
7 XBRL DEFINITION FILE abeo-20240630_def.xml EX-101.DEF 195526
8 XBRL LABEL FILE abeo-20240630_lab.xml EX-101.LAB 456113
9 XBRL PRESENTATION FILE abeo-20240630_pre.xml EX-101.PRE 365085
80 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1284960
Mailing Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103
Business Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15771 | Film No.: 241194758
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)